Summary

Nebulized furosemide to treat breathlessness in emergency patients with advanced cancer

Quiñones Pérez A, Álvarez Jiménez P, García Sánchez MJ, Ferrer Frías MM

Affiliation of the authors

Unidad de Gestión Clínica de Cuidados Críticos y Urgencias. Equipo de Soporte de Cuidados Paliativos. Unidad de Gestión Clínica del Bloque Quirúrgico. Área de Gestión Sanitaria Sur de Granada. Motril. Granada, Spain.

DOI

Quote

Quiñones Pérez A, Álvarez Jiménez P, García Sánchez MJ, Ferrer Frías MM. Nebulized furosemide to treat breathlessness in emergency patients with advanced cancer. Emergencias. 2011;23:208-10

Summary

Three patients with advanced cancer and acute dyspnea for different reasons were

treated with furosemide spray in a hospital emergency department. A single dose of 40

mg of nebulized furosemide was sprayed and inhaled in a single dose. Breathlessness

improved significantly, bringing the episode under control, in patients with at least 50%

of function according to the Palliative Performance Status (PPS) scale. However,

furosemide did not improve the condition of a patient with end-stage dyspnea. No

adverse effects were observed. Inhaling nebulized furosemide seems to be an effective

treatment for breathlessness in patients with terminal cancer and a 50% PPS function

assessment, although randomized controlled trials are needed to confirm this

hypothesis.

 

More articles by the authors